- 24/7 Technology,Internet,Bio Patent and Intellectual Property News & Information Service
-
SUBSCRIBE TO FEED
- Who are patent attorneys?
- What are patents, and how long are they in force?
- Valuing patents
- Steps in the Patent Process
- Intellectual Property and patents thereof
- History of Patents and Patent Law
- Copyrights & Copyright Law History
- Historically Famous U.S. patents
- Comparing Patents & Copyrights
- Applying for a Patent? Follow these steps
-
Articles
'Disease' Tag
-
U-M scientists identify new reservoir for hidden HIV-infected cells that can serve as factory for new infections
March 8, 2010[Story ID: 736]
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS [...] -
Inability to motivate diabetics with poor control to overcome barriers inhibiting healthier lifestyles frustrates physicians
March 6, 2010[Story ID: 726]
Diabetes affects approximately 8 percent of the people in the United States and adults with diabetes have heart disease death rates two to four times higher than adults without diabetes, according to the American Diabetes Association. A new study shows that primary care physicians believe the barriers that put patients with uncontrolled diabetes [...] -
NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD
March 2, 2010[Story ID: 652]
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by [...] -
Genetic Disorder Tracker introduced by Guidepoint Global
February 25, 2010[Story ID: 598]
Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher’s disease, Fabry’s disease, PKU, MPS I (Hurler Syndrome), MPS II (Hunter Syndrome), MPS [...] -
Blood test to detect elevated levels of antibodies unique to Alzheimers disease developed
February 12, 2010[Story ID: 336]
OPKO Health, Inc. today announced the development of a simple diagnostic blood test for Alzheimer’ -
Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented
February 12, 2010[Story ID: 340]
Protalix BioTherapeutics, Inc., announced today that additional data from the Company’s pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, “Novel Enzyme Replacement Therapy for Gaucher Disease: [...] -
Study could lead to new therapeutic strategies for Parkinsons disease
February 10, 2010[Story ID: 299]
A new study from The Montreal Neurological Institute and Hospital – The Neuro – at McGill University is the first to discover a molecular link between Parkinson’s disease and defects in the ability of nerve cells to communicate. -
Stronger animal disease traceability system will help minimize harm to other food animals, food producers and the public
February 6, 2010[Story ID: 246]
In response to a statement by Agriculture Secretary Tom Vilsack today, the American Veterinary Medical Association (AVMA) is reaffirming its call for a strong, national animal disease traceability program to help maintain and improve the health of U.S. livestock. -
American Heart Month aims to spread awareness of women and heart disease
February 5, 2010[Story ID: 224]
More than five times as many women are diagnosed with heart disease each year than with breast cancer. American Heart Month in February aims to spread awareness of women and heart disease, and one Alabama company has found the quickest way to a woman’s heart might be through her gynecologist. -
WORLD Symposium: Protalix Biotherapeutics to present data on taliglucerase alfa Phase III Gaucher disease trial
February 5, 2010[Story ID: 225]
Protalix Biotherapeutics, Inc. today announced that data from its pivotal Phase III trial of taliglucerase alfa in patients with Gaucher disease will be presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010, February 10-12, 2010 in Miami, Florida.